Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
CLP-d2
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CLP-d2 is a multi-target anti-inflammatory agent, osteoclastogenesis inhibitor, and immunomodulator with pharmacokinetic properties superior to Daptomycin and excellent safety. It reduces c-Fos and NFATc1 expression levels, decreases phosphorylation of IκBα, p65, ERK, and JNK, and inhibits the NF-κB and MAPK signaling pathways, thereby reducing the secretion of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β, demonstrating anti-inflammatory activity. CLP-d2 inhibits osteoclast formation within mouse joints, alleviating bone erosion and joint swelling, reducing synovial hyperplasia and inflammatory cell infiltration, and lowering serum rheumatoid factor (RF) levels. It is applicable for research related to rheumatoid arthritis. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.